Literature DB >> 15802062

Factors influencing patient choice for bariatric operation.

Christine J Ren1, Izumi Cabrera, Kavitha Rajaram, George A Fielding.   

Abstract

BACKGROUND: No study has surveyed the factors that influence morbidly obese patients' preference for a particular bariatric operation.
METHOD: 469 consecutive patients in 2 major bariatric surgery centers in the United States (US, 124) and Australia (AU, 345) were prospectively studied to determine referral pattern and reason for their choice of operation.
RESULTS: The predominant operation was laparoscopic adjustable gastric banding (LAGB) in both US (75%) and AU (83%) centers. Gender (70% female), BMI (45 kg/m2) and age (42.5 years) were similar in both cohorts. In Australia, 53% had referral initiated by primary doctors and 25% by another patient, while in the US, 43% by another patient and 27% by the Internet. Safety of the operation (43%) was the highest-rated factor in choosing LAGB. LAGB being "least invasive" was most significant in the US (46%), and "surgical safety" in Australia (45%). In the US, Rouxen-Y gastric bypass was preferred due to "lack of a foreign body" (31%) and "inability to cheat" (28%), while in Australia, "dumping" was the most significant reason (50%). Duodenal switch (BPD/DS) was selected in 11% of patients, primarily because of "durability of the weight loss" (51%). Surprisingly, only 1 patient in the US group selected BPD/DS because the pylorus remains intact.
CONCLUSION: Safety and invasiveness had the greatest impact on patient choice for bariatric operation in two different countries. This information may help clinicians better understand their patients' concerns, and their treatment choices.

Entities:  

Mesh:

Year:  2005        PMID: 15802062     DOI: 10.1381/0960892053268444

Source DB:  PubMed          Journal:  Obes Surg        ISSN: 0960-8923            Impact factor:   4.129


  9 in total

1.  Psychological assessments of bariatric surgery patients. Development, reliability, and exploratory factor analysis of the PsyBari.

Authors:  David Mahony
Journal:  Obes Surg       Date:  2011-09       Impact factor: 4.129

2.  Early U.S. outcomes of laparoscopic gastric bypass versus laparoscopic adjustable silicone gastric banding for morbid obesity.

Authors:  T H Kim; A Daud; A O Ude; M DiGiorgi; L Olivero-Rivera; B Schrope; D Davis; W B Inabnet; M Bessler
Journal:  Surg Endosc       Date:  2005-12-06       Impact factor: 4.584

Review 3.  Laparoscopic bariatric surgery.

Authors:  B Schirmer
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

4.  Evaluating the quality of internet information for bariatric surgery.

Authors:  Khalid Akbari; Robin Som
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

5.  Do patients seeking laparoscopic adjustable gastric banding surgery differ from those seeking gastric bypass surgery? A comparison of psychological profiles across ethnic groups.

Authors:  Megan M Hood; Joyce A Corsica; Leila Azarbad
Journal:  Obes Surg       Date:  2011-04       Impact factor: 4.129

6.  Patient preferences and bariatric surgery procedure selection; the need for shared decision-making.

Authors:  Andrew L Weinstein; Bryan J Marascalchi; Matthew A Spiegel; John K Saunders; Angela Fagerlin; Manish Parikh
Journal:  Obes Surg       Date:  2014-11       Impact factor: 4.129

7.  Patient Preferences for Bariatric Surgery: Findings From a Survey Using Discrete Choice Experiment Methodology.

Authors:  Michael D Rozier; Amir A Ghaferi; Angela Rose; Norma-Jean Simon; Nancy Birkmeyer; Lisa A Prosser
Journal:  JAMA Surg       Date:  2019-01-16       Impact factor: 14.766

8.  Bariatric surgery for obesity: surgical approach and variation in in-hospital complications in New York State.

Authors:  Michael L Lindsey; Wendy L Patterson; Foster C Gesten; Patrick J Roohan
Journal:  Obes Surg       Date:  2009-02-27       Impact factor: 4.129

9.  Patient preferences regarding bariatric/metabolic procedures: a survey of Korean obese candidates for surgery.

Authors:  Su Yeon Roh; Yeon Ho Park; Woon Ki Lee; Seong Min Kim
Journal:  Ann Surg Treat Res       Date:  2020-01-31       Impact factor: 1.859

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.